MENU
RAPP
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Rapport Therapeutics (RAPP) Ownership - Who owns Rapport Therapeutics?

Rapport Therapeutics Inc is a clinical-stage biotechnology company dedicated to the discovery and development of small-molecule precision medicines for patients with neurological or psychiatric disorders... Show more

Profile

Industry
N/A
Address
99 High Street
Phone
+1 857 321-8020
Employees
84
Web
https://www.rapportrx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.41B
P/E Ratio
-9.69
Total Cash
436.08M
Projected Growth
N/A
Total Debt
10.11M
Revenue
20M
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
9.09
Total Debt/Equity
N/A
Revenue/Share
0.45 USD as % of share price
Who owns Rapport Therapeutics? RAPP symbol Ownership - Tickeron.com